Antimicrobial PLGA ultrafine fibers: interaction with wound bacteria

Eur J Pharm Biopharm. 2011 Sep;79(1):108-18. doi: 10.1016/j.ejpb.2011.03.002. Epub 2011 Mar 9.

Abstract

The structure and functions of polymer nanofibers as wound dressing materials have been well investigated over the last few years. However, during the healing process, nanofibrous mats are inevitably involved in dynamic interactions with the wound environment, an aspect not explored yet. Potential active participation of ultrafine fibers as wound dressing material in a dynamic interaction with wound bacteria has been examined using three wound bacterial strains and antimicrobial fusidic acid (FA)-loaded electrospun PLGA ultrafine fibers (UFs). These were developed and characterized for morphology and in-use pharmaceutical attributes. In vitro microbiological studies showed fast bacterial colonization of UFs and formation of a dense biofilm. Interestingly, bacterial stacks on UFs resulted in a remarkable enhancement of drug release, which was associated with detrimental changes in morphology of UFs in addition to a decrease in pH of their aqueous incubation medium. In turn, UFs by allowing progressively faster release of bioactive FA eradicated planktonic bacteria and considerably suppressed biofilm. Findings point out the risk of wound reinfection and microbial resistance upon using non-medicated or inadequately medicated bioresorbable fibrous wound dressings. Equally important, data strongly draw attention to the importance of characterizing drug delivery systems and establishing material-function relationships for biomedical applications under biorelevant conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / chemistry*
  • Anti-Infective Agents / pharmacology
  • Bacteria
  • Bandages
  • Biofilms / drug effects
  • Drug Compounding
  • Drug Delivery Systems*
  • Drug Evaluation, Preclinical
  • Fusidic Acid / chemistry*
  • Fusidic Acid / pharmacokinetics
  • Fusidic Acid / pharmacology
  • Lactic Acid / chemistry*
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / metabolism
  • Microbial Sensitivity Tests
  • Nanofibers
  • Particle Size
  • Plankton / drug effects
  • Plankton / metabolism
  • Polyglycolic Acid / chemistry*
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polymers / chemistry*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / metabolism
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / metabolism
  • Surface Properties
  • Wound Healing / physiology
  • Wound Infection / microbiology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Polymers
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Fusidic Acid